In public health sectors of many developing countries, patients offer payments to their doctors outside the official payment channels. We argue that the fundamental cause of informal payments is that formal prices cannot fully differentiate patients' various needs. We compare welfare...

We build up a differential game to investigate the interplay between the quality of health care and the presence of an evolving disease in a duopoly where patients are heterogeneous along the income dimension. We prove unicity, stability and perfection of the open-loop Nash solution. Moreover,...

Health policy makers in developing, low income countries are often faced with difficult choices and tradeoffs in allocating the rather limited resources at their disposal. This paper analyzes the varied approaches taken by the Governments of China and India which resulted in differential levels...

These are neither the best of times nor the worst of times for the pharmaceutical industry, or for global public health. Media reports regarding recent legal developments would suggest that the originator pharmaceutical industry is facing a new and dangerous threat to its long-term welfare,...

We analyze prescription behavior of physicians in the public and private sector. We study two major diseases for which an effective, widely accepted low-cost treatment and alternative, more expensive treatments are available. We find that private sector physicians are more likely to prescribe...

Evidence on how digital technologies, such as online health information platforms, affect the doctor-patient relationship in general, and the diagnosis and treatment of patients in particular, is still limited. In this study, we explore the effects of alternative information from an online...

We build up a differential game to investigate the interplay between the quality of health care and the presence of an evolving disease in a duopoly where patients are heterogeneous along the income dimension. We prove unicity, stability and perfection of the open-loop Nash solution. Moreover,...

I give a brief summary of the institutional details of the U.S. healthcare sector with a special emphasis on healthcare finance. In addition to its large size, U.S. healthcare has four unique features that can be used to help answer corporate finance questions: segmented markets, variation in...